These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3840290)

  • 1. Inhibition by AD6 (8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxycarbonyl methoxy coumarin) of platelet aggregation in dog stenosed coronary artery.
    Prosdocimi M; Finesso M; Tessari F; Gorio A; Languino LR; de Gaetano G; Dejana E
    Thromb Res; 1985 Aug; 39(4):399-409. PubMed ID: 3840290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Action of AD6 (8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxycarbonylmet hox y coumarin) on human platelets in vitro.
    Prosdocimi M; Zatta A; Gorio A; Zanetti A; Dejana E
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Mar; 332(3):305-10. PubMed ID: 3012375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of 8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxy carboxyl methoxy coumarin (AD6) on aggregation, arachidonic acid metabolism and thromboxane B2 formation in human platelets.
    Galli C; Agradi E; Petroni A; Socini A
    Pharmacol Res Commun; 1980 Apr; 12(4):329-37. PubMed ID: 7393988
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of AD6 (8-monochloro-3-beta-diethylamino-ethyl-4-methyl-7-ethoxy- carbonylmethoxycoumarin) on washed human platelet aggregation induced by platelet activating factor (PAF) and epinephrine.
    Zanetti A; Zatta A; Prosdocimi M; Dejana E
    Eur J Pharmacol; 1986 Aug; 128(1-2):119-27. PubMed ID: 2944757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AD6 (8-monochloro-3-beta-diethylamino-ethyl-4-methyl-7-ethoxycarbonyl-meth oxy coumarin) inhibits the release of arachidonic acid in human platelets stimulated by thrombin.
    Porcellati S; Costantini V; Prosdocimi M; Pistolesi R; Porrovecchio P; Nenci GG; Goracci G
    Thromb Res; 1987 Jul; 47(1):15-24. PubMed ID: 3116710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic blood flow variations induced by platelet-activating factor in stenosed canine coronary arteries despite inhibition of thromboxane synthetase, serotonin receptors, and alpha-adrenergic receptors.
    Apprill P; Schmitz JM; Campbell WB; Tilton G; Ashton J; Raheja S; Buja LM; Willerson JT
    Circulation; 1985 Aug; 72(2):397-405. PubMed ID: 2988822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of antiplatelet activity of the new coumarin derivative 8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxy- carboxylmethoxycoumarin under in vivo conditions in man.
    Luzzatto G; Fabris F; Dal Bo Zanon R; Girolami A
    Arzneimittelforschung; 1986 Jun; 36(6):972-3. PubMed ID: 2943294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the coumarin derivative AD6 on platelet aggregation, platelet vessel wall interactions and 6 keto PGF1 alpha production in perfused aortas, in experimentally hypercholesterolaemic rabbits.
    Socini A; Petroni A; Colli S; Colombo C; Galli C
    Pharmacol Res Commun; 1982 Mar; 14(3):189-97. PubMed ID: 7048340
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of aspirin on local prostaglandin production and serotonin accumulation in a canine model with coronary cyclic flow variations or thrombosis.
    Yao SK; Benedict CR; Rosolowsky M; McNatt J; Falinska B; Campbell WB; Buja LM; Willerson JT
    J Mol Cell Cardiol; 1991 Apr; 23(4):473-82. PubMed ID: 1942081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteries.
    Yao SK; Ober JC; McNatt J; Benedict CR; Rosolowsky M; Anderson HV; Cui K; Maffrand JP; Campbell WB; Buja LM
    Circ Res; 1992 Jan; 70(1):39-48. PubMed ID: 1727687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies on inhibition of platelet aggregation by carbocromen (author's transl)].
    Resag K; Melzer G; Nitz RE
    Arzneimittelforschung; 1976 Feb; 26(2):209-13. PubMed ID: 947200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tocotrienols-induced inhibition of platelet thrombus formation and platelet aggregation in stenosed canine coronary arteries.
    Qureshi AA; Karpen CW; Qureshi N; Papasian CJ; Morrison DC; Folts JD
    Lipids Health Dis; 2011 Apr; 10():58. PubMed ID: 21489303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose droperidol protects against experimental coronary thrombosis in dogs and pigs and attenuates aggregation of porcine platelets and Ca2+ mobilization in human platelets.
    Bertha BG; Sill JC; Berger I; Folts JD; Milde JH
    Anesthesiology; 1993 Apr; 78(4):733-43. PubMed ID: 8466073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of AD6 (8-monochloro-3-beta-diethylamino-ethyl-4-methyl-7-ethoxycarbonylme tho xy coumarin) on cyclic nucleotide phosphodiesterases in human platelets.
    Hakim G; Fiorentini D; Falasca A; Prosdocimi M; Rossi CA
    Experientia; 1988 Mar; 44(3):226-8. PubMed ID: 2832208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
    Ramjit DR; Lynch JJ; Sitko GR; Mellott MJ; Holahan MA; Stabilito II; Stranieri MT; Zhang G; Lynch RJ; Manno PD
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The beneficial effects of nafazatrom (BAYg6575) on experimental coronary thrombosis.
    Shea MJ; Driscoll EM; Romson JL; Pitt B; Lucchesi BR
    Am Heart J; 1984 Apr; 107(4):629-37. PubMed ID: 6702555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of cigarette smoke and nicotine on platelet thrombus formation in stenosed dog coronary arteries: inhibition with phentolamine.
    Folts JD; Bonebrake FC
    Circulation; 1982 Mar; 65(3):465-70. PubMed ID: 7055868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental coronary artery thrombosis in the absence of thromboxane A2 synthesis: evidence for alternate pathways for coronary thrombosis.
    Hook BG; Schumacher WA; Lee DL; Jolly SR; Lucchesi BR
    J Cardiovasc Pharmacol; 1985; 7(1):174-81. PubMed ID: 2580139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epinephrine potentiation of in vivo stimuli reverses aspirin inhibition of platelet thrombus formation in stenosed canine coronary arteries.
    Folts JD; Rowe GG
    Thromb Res; 1988 May; 50(4):507-16. PubMed ID: 3413717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term and long-term role of platelet activating factor as a mediator of in vivo platelet aggregation.
    Golino P; Ambrosio G; Ragni M; Pascucci I; Triggiani M; Oriente A; McNatt J; Buja LM; Condorelli M; Chiariello M
    Circulation; 1993 Sep; 88(3):1205-14. PubMed ID: 8353882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.